Blood Cell Separation Market Size, Share & Industry Analysis, By Product (Consumables, Instruments), By Cell Type (Human Cells, Animal Cells), By Technique (Centrifugation-based Cell Isolation, Surface marker-based Cell Isolation, Filtration-based Cell Isolation), By Application (Biomolecule Isolation, Cancer Research, Stem Cell Research, In-vitro Diagnostics), By End-User (Research Laboratories & Institutes, Hospitals) and Regional Forecast, 2024-2032

Blood cell separation is one of the crucial processes which involves the removal of one cell population from another within a biological sample, such as blood or tissue. The common purpose of this technique is testing the various blood components according to medical prescriptions. The isolation of cells depends upon the properties of cells such as surface markers, surface charge and adhesion, density, and cell size. Increasing incidence and prevalence of chronic diseases with the aging population, technological advancement in cell separation technologies, and growing demand for biopharmaceutical and personalized medicine are some of the factors that are expected to augment the market growth during the forecast period. For instance, according to GLOBOCAN 2018, there were about 18.1 million new cancer cases reported, worldwide      

Increasing incidence and prevalence of chronic diseases with the aging population, technological advancement in cell separation technologies, and growing demand for biopharmaceutical and personalized medicine are some of the factors that are driving the market growth.

However, high costs associated with blood cell separation technologies is likely to decline the growth of the blood cell separation market.  

Market Segmentation:

By product, the market can be segmented into consumables and instruments. By consumables, the market can be further segmented into reagents, kits, and beads. By instruments, the market can be further segmented into centrifuges, flow cytometers, and filtration systems. By cell type, the market can be segmented into human cells and animal cells. By technique, the market can be segmented into centrifugation-based cell isolation, surface marker-based cell isolation, and filtration-based cell isolation. By application, the market can be segmented into biomolecule isolation, cancer research, stem cell research, and in-vitro diagnostics. By end-users, the market can be segmented into research laboratories & institutes, hospitals, biotechnology & biopharmaceutical companies, and others

Geographically, the blood cell separation market can be segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa.

Key Players Covered:

The major companies in the global blood cell separation market report includes Thermo Fisher Scientific Inc., Beckman Coulter, Inc., GENERAL ELECTRIC COMPANY, Merck KGaA, STEMCELL Technologies Inc., Bio-Rad Laboratories, Inc., TERUMO BCT, INC. and other prominent players.

Key Insights

• Prevalence of chronic diseases (cancer)


• Product Mapping by Key Players


• Technological Advancements in Blood Cell Separation Technologies


• Key Industry Developments – Mergers & Acquisitions, Partnerships, New Products Introduction

Regional Analysis:

The global blood cell separation market is expected to be segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America is anticipated to lead the global blood cell separation market due to an increasing prevalence of chronic disorders (cancer, cardiovascular diseases) in the U.S. According to the National Cancer Institute, about 1,735,350 new cancer cases were reported in 2018 in United States. Also, the availability of improved healthcare facilities and research and development in blood cell separation are responsible factors for its dominance. Europe is likely to have substantial market growth throughout the forecast period owing to the rising geriatric population, and rising prevalence of chronic disorders. Asia Pacific and Latin America are expected to register fast market growth during the forecast period due to the increasing number of chronic disorders, and rising awareness about the blood cell separation technologies among the people. On the other hand, the Middle East and Africa is projected to have a lucrative growth in blood cell separation market in the upcoming years owing to the lack of enough research and development activities in blood cell separation technologies due to limited availability of resources

Segmentation

Blood Cell Separation Industry Developments

• In November 2019, MicroMedicine, Inc., a life sciences technology company launched its patented automated, microfluidics based technology at the Society for Immunotherapy of Cancer (SITC) meeting.


• In May 2019, Akadeum Life Sciences launched seven new products at Immunology 2019 Conference in San Diego based on microbubble technology, which uses buoyancy to gently separate cells of interest within the tube.


• In February 2019, Institute of Life Sciences (ILS) launched a magnetic cell separation kit, useful for researchers and medical practitioners in separating different types of cells for analysis and study.